Dr. Halperin has nearly 20 years of medical experience in the pharmaceutical industry. Until 2010, she was the Medical Director at Teva, in charge of Regulatory affairs, Clinical Trials and Medical Marketing in the Israel and International Group (non U.S. and E.U. countries). She is currently in charge of Medical and Scientific affairs at CH-Health, a private venture capital in Israel. CH has invested in 10 companies in the Biotech field, in different stages of drugs/devices development. Two of its portfolio companies
have held successful NASDAQ IPOs and the others are private. She was active in the NASDAQ IPO and recently served as a member of the board of Galmed.